International Journal of Epidemiology, Vol 26, 730-738, Copyright © 1997 by International Epidemiological Association
JD Kark, M Leinonen, O Paltiel and P Saikku
BACKGROUND: A number of studies in European and North American populations
have reported associations between Chlamydia pneumoniae seropositivity and
coronary heart disease (CHD). Our objective was to assess the association
of IgG and IgA antibodies to C. pneumoniae with acute myocardial infarction
(MI) in a population-based case-control study in a Middle Eastern country.
METHODS: Eligible cases aged 25-64 with a first acute MI were ascertained
through an active surveillance system in Jerusalem hospitals between 1987
and 1989 (85% response). Controls were Jerusalem residents aged 25-64
sampled from the national population registry (83% response). Data on
sociodemographic variables, CHD history and risk factors were collected by
interview. Chlamydia serology, available for 93% of eligible participants,
was performed by microimmunofluorescence on frozen stored samples using the
TWAR antigen. Altogether, 251 male and 51 female cases, and 324 male and
162 female controls were analysed. RESULTS: Overall, high IgG titres (>
or = 128) were not associated with increased risk of acute MI (Odds ratio
[OR] = 0.74 for men [95% confidence interval (CI): 0.47-1.17] and 0.91 for
women [95% CI: 0.43-1.94]); neither were high IgA titres (> or = 80) (OR
= 1.11 for men [95% CI: 0.71-1.73] and 1.15 for women [95% CI: 0.33-4.0]).
At IgG and IgA titres of > 32 and > 20 respectively there was also no
relation. CONCLUSIONS: An association of C. pneumoniae seropositivity with
acute MI was not confirmed in this population with a very high IgG
seropositivity prevalence of 84% in males and 69% in females. However, we
cannot exclude the possibility that a postulated recent outbreak obscured
an association with chronic C. pneumoniae infection.
ARTICLES
Chlamydia pneumoniae and acute myocardial infarction in Jerusalem
Epidemiology Unit, Hadassah Medical Organization, Jerusalem, Israel.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. D Kark, N. A Kaufmann, F. Binka, N. Goldberger, and E. M Berry Adipose tissue n-6 fatty acids and acute myocardial infarction in a population consuming a diet high in polyunsaturated fatty acids Am. J. Clinical Nutrition, April 1, 2003; 77(4): 796 - 802. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Schumacher, A. B. Lerkerød, I. Seljeflot, L. Sommervoll, I. Holme, J. E. Otterstad, and H. Arnesen Chlamydia pneumoniae Serology: Importance of Methodology in Patients with Coronary Heart Disease and Healthy Individuals J. Clin. Microbiol., May 1, 2001; 39(5): 1859 - 1864. [Abstract] [Full Text] |
||||
![]() |
K. Aalto-Setala, K. Laitinen, L. Erkkila, M. Leinonen, M. Jauhiainen, C. Ehnholm, M. Tamminen, M. Puolakkainen, I. Penttila, and P. Saikku Chlamydia pneumoniae Does Not Increase Atherosclerosis in the Aortic Root of Apolipoprotein E-Deficient Mice Arterioscler. Thromb. Vasc. Biol., April 1, 2001; 21(4): 578 - 584. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ericson, T. G. P. Saldeen, O. Lindquist, C. Pahlson, and J. L. Mehta Relationship of Chlamydia pneumoniae Infection to Severity of Human Coronary Atherosclerosis Circulation, June 6, 2000; 101(22): 2568 - 2571. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hoffmeister, D. Rothenbacher, P. Wanner, G. Bode, K. Persson, H. Brenner, V. Hombach, and W. Koenig Seropositivity to chlamydial lipopolysaccharide and chlamydia pneumoniae, systemic inflammation and stable coronary artery disease: Negative results of a case-control study J. Am. Coll. Cardiol., January 1, 2000; 35(1): 112 - 118. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-k. Wong, K. D. Dawkins, and M. E. Ward Circulating chlamydia pneumoniae DNA as a predictor of coronary artery disease J. Am. Coll. Cardiol., November 1, 1999; 34(5): 1435 - 1439. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y-K Wong, P J Gallagher, and M E Ward Chlamydia pneumoniae and atherosclerosis Heart, March 1, 1999; 81(3): 232 - 238. [Abstract] [Full Text] |
||||
![]() |
L J Murray, D P J O'Reilly, G M L Ong, C O'Neill, A E Evans, and K B Bamford Chlamydia pneumoniae antibodies are associated with an atherogenic lipid profile Heart, March 1, 1999; 81(3): 239 - 244. [Abstract] [Full Text] |
||||
![]() |
Y.-k. Wong, M. Thomas, V. Tsang, P. J. Gallagher, and M. E. Ward The prevalence of Chlamydia pneumoniae in atherosclerotic and nonatherosclerotic blood vessels of patients attending for redo and first time coronary artery bypass graft surgery J. Am. Coll. Cardiol., January 1, 1999; 33(1): 152 - 156. [Abstract] [Full Text] [PDF] |
||||





